Treatment of cancer with phlorizin and its derivatives
US4840939A · kind A · utility
34Cited by
2References
26Claims
0Family size
Inventors
Key dates
| Filing date | Mar 18, 1987 |
| Grant date | Jun 20, 1989 |
| Priority date | — |
| Expiry date | Mar 18, 2007 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07H17/07
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Malignant, neoplastic cells are treated by inhibiting glucose transport into the cell by administering phlorizin, phloretin or its analogs while concurrently administering adjunct therapy such as heat, radiation or chemotherapy. In this manner, the cells are prevented from growing or repairing the damage caused by the adjunct therapy, which can be administered in dosages that would otherwise be non-lethal if used alone.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.